Abstract
Bone tissue pathology can generate irreversible defects that are not capable of regenerating by themselves. The current therapeutic approaches are based on native bone tissue grafts, either autologous or heterologous. However, these clinical approaches are commonly associated to morbidity, immunogenicity and availability. In this sense, Tissue Engineering allows, through the development of cellular constructs, a new therapeutic approach that aims to improve current ones. The specific properties of the bone tissue require an adequate selection of biomaterials used as a scaffold of the cellular construct as a bone substitute.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.